Carl Zeiss Meditec AG (AFX) — Cash Flow-to-Debt Ratio
Carl Zeiss Meditec AG (AFX) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €144.16 Million could theoretically repay 0% of its total liabilities (€1.28 Billion) in one year. See how much free cash does Carl Zeiss Meditec AG generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Carl Zeiss Meditec AG Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Carl Zeiss Meditec AG across 12 annual periods. Also explore AFX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year debt coverage analysis for Carl Zeiss Meditec AG. For market capitalisation and broader financial context, see how much is Carl Zeiss Meditec AG worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €209.86 Million | €1.28 Billion | ▼ -11.1% |
| 2024 | 0.19x | €247.32 Million | €1.34 Billion | ▼ -36.6% |
| 2023 | 0.29x | €250.86 Million | €860.02 Million | ▲ +22.9% |
| 2022 | 0.24x | €188.20 Million | €792.73 Million | ▼ -53.0% |
| 2021 | 0.50x | €362.66 Million | €718.59 Million | ▲ +59.1% |
| 2020 | 0.32x | €178.53 Million | €562.73 Million | ▼ -12.6% |
| 2019 | 0.36x | €219.63 Million | €605.17 Million | ▼ -32.6% |
| 2018 | 0.54x | €187.21 Million | €347.42 Million | ▲ +444.6% |
| 2017 | 0.10x | €37.73 Million | €381.37 Million | ▼ -64.9% |
| 2016 | 0.28x | €111.77 Million | €396.57 Million | ▲ +69.8% |
| 2015 | 0.17x | €56.74 Million | €341.84 Million | ▼ -25.1% |
| 2014 | 0.22x | €63.10 Million | €284.88 Million | — |